1\. O'Sullivan B, Huang SH, Su J, et al. Development and validation of
a staging system for HPV-related oropharyngeal cancer by the
International Collaboration on Oropharyngeal cancer Network for
Staging (ICON-S): a multicentre cohort study. The lancet oncology.
Feb 26 2016.  
2\. Patel S. Personal Communication. In: Lydiatt W, Shah JP, eds.
2015\.  
3\. Wreesmann VB, Katabi N, Palmer FL, et al. Influence of extracap-
sular nodal spread extent on prognosis of oral squamous cell carci-
noma. Head & neck. Oct 30 2015.  
4\. de Juan J, Garcia J, Lopez M, et al. Inclusion of extracapsular
spread in the pTNM classification system: a proposal for patients
with head and neck carcinoma. JAMA otolaryngology- head &
neck surgery. May 2013;139(5):483-488.  
5\. Prabhu RS, Hanasoge S, Magliocca KR, et al. Extent of pathologic
extracapsular extension and outcomes in patients with nonoropha-
ryngeal head and neck cancer treated with initial surgical resection.
Cancer. May 15 2014;120(10):1499-1506.  
6\. Dunne AA, Muller HH, Eisele DW, Kessel K, Moll R, Werner
JA. Meta-analysis of the prognostic significance of perinodal spread
in head and neck squamous cell carcinomas (HNSCC) patients.
European journal of cancer. Aug 2006;42(12):1863-1868.  
7\. Prabhu RS, Magliocca KR, Hanasoge S, et al. Accuracy of com-
puted tomography for predicting pathologic nodal extracapsular
extension in patients with head-and-neck cancer undergoing initial
surgical resection. International journal of radiation oncology,
biology, physics. Jan 1 2014;88(1):122-129.  
8\. Piccirillo JF. Inclusion of comorbidity in a staging system for head
and neck cancer. Oncology (Williston Park). Sep 1995;9(9):831-
836; discussion 841, 845-838.  
9\. Marion E. Couch MD P, MBA1,*, Kim Dittus MD, PhD2, Michael
J. Toth PhD3, Monte S. Willis MD, PhD4, Denis C. Guttridge
PhD5, Jonathan R. George MD6, Eric Y. Chang7, Christine
G. Gourin MD8 andHirak Der-Torossian MD, MPH1 Cancer
cachexia update in head and neck cancer: Pathophysiology and
treatment Head & neck surgery. 2015;37(7):1057-1072.  
10\. Lazure KE, Lydiatt WM, Denman D, Burke WJ. Association
between depression and survival or disease recurrence in patients
with head and neck cancer enrolled in a depression prevention trial.
Head & neck. 2009;31(7):888-892.  
11\. Kattan MW, Hess KR, Amin MB, et al. American Joint Committee
on Cancer acceptance criteria for inclusion of risk models for indi-
vidualized prognosis in the practice of precision medicine. CA: a
cancer journal for clinicians. Jan 19 2016.  
<!-- PageNumber="13" -->
<!-- PageBreak -->  
<!-- PageBreak -->